Vascular endothelial growth factor (VEGF) in neuroendocrine (NE) cells: A marker of prostate cancer (PCA) progression modulated by hormone ablation

被引:0
|
作者
Andonian, S
Dam, V
Begin, L
Chevalier, S
Aprikian, A
机构
来源
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:227 / 227
页数:1
相关论文
共 50 条
  • [1] Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
    Ferrer, FA
    Miller, LJ
    Andrawis, RI
    Kurtzman, SH
    Albertsen, PC
    Laudone, VP
    Kreutzer, DL
    JOURNAL OF UROLOGY, 1997, 157 (06): : 2329 - 2333
  • [2] Vascular Endothelial Growth Factor (VEGF) and Prostate Pathology
    Botelho, Francisco
    Pina, Francisco
    Silva, Pedro
    Figueiredo, Gabriela
    Cruz, Francisco
    Lunet, Nuno
    INTERNATIONAL BRAZ J UROL, 2010, 36 (04): : 430 - 437
  • [3] The vascular endothelial growth factor (VEGF) as an autocrine and resistance factor to apoptosis in human prostate cancer cells(LNCaP)
    Colon, NM
    Buttyan, R
    MOLECULAR BIOLOGY OF THE CELL, 1999, 10 : 40A - 40A
  • [4] Vascular endothelial growth factor (VEGF) signaling in tumor progression
    Roskoski, Robert, Jr.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (03) : 179 - 213
  • [5] Cancer Marker: Vascular Endothelial Growth Factor
    Keiichi Mitsuyama
    Atsushi Toyonaga
    Kazuhiro Fujisaki
    Kyuichi Tanikawa
    Digestive Diseases and Sciences, 1998, 43 : 1695 - 1696
  • [6] Vascular endothelial growth factor (VEGF) as a marker for colorectal cancer and inflammatory bowel disease
    Grenshaw, DE
    Muller, BR
    Thillainayagam, AV
    CLINICA CHIMICA ACTA, 2005, 355 : S428 - S428
  • [7] Cancer marker: Vascular endothelial growth factor
    Mitsuyama, K
    Toyonaga, A
    Fujisaki, K
    Tanikawa, K
    Matsuo, K
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (08) : 1695 - 1696
  • [8] Vascular endothelial growth factor (VEGF) - A new tumour marker for colorectal cancer.
    Kumar, H
    Heer, K
    Greenman, J
    Lee, PWR
    Duthie, GS
    Kerin, MJ
    Monson, JRT
    GUT, 1998, 42 : A15 - A15
  • [9] PROGNOSTIC VALUE OF QUANTIFYING CIRCULATING TUMOURAL CELLS (CTC), CIRCULATING ENDOTHELIAL CELLS (CEC) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN HORMONE SENSITIVE METASTATIC PROSTATE CANCER
    San Jose Manso, L.
    Olivier Gomez, C.
    Resel Folkersma, L.
    Galante Romo, I.
    Leon Rueda, M. E.
    Campanario, F.
    Casado, J.
    Hernando Arteche, A.
    Useros, E.
    Sanz Casla, M. T.
    Vidaurreta, M.
    De La Orden, V.
    Diaz Rubio, E.
    De Las Casas, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 116 - 117
  • [10] RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation
    F Rinaldo
    J Li
    E Wang
    M Muders
    K Datta
    Oncogene, 2007, 26 : 1731 - 1738